Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RNASE6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TMEM60 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RFPL1S - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC2A3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ARHGAP28 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RGL3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANKRD24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OGFOD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100653296 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CPB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TEKT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL6A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGRMC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MIR943 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FRMD4B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on